AbCellera Biologics Inc. (ABCL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:03PM EDT. Market open.
| Previous close | 3.7800 |
| Open | 3.8900 |
| Bid | 3.7900 x 2200 |
| Ask | 3.8100 x 100 |
| Day's range | 3.6800 - 3.8900 |
| 52-week range | 3.6200 - 8.0500 |
| Volume | |
| Avg. volume | 1,374,706 |
| Market cap | 1.118B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
VANCOUVER, British Columbia, May 01, 2024--AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
- Business Wire
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
VANCOUVER, British Columbia, April 08, 2024--AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
- Business Wire
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
VANCOUVER, British Columbia, April 03, 2024--AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
© 2024 Yahoo. All rights reserved.